AEROVATE THERAPEUTICS INC (AVTE) Stock Price, Forecast & Analysis
USA - NASDAQ:AVTE - US0080641071 - Common Stock
AVTE Key Statistics, Chart & Performance
The current stock price of AVTE is 2.68 USD. In the past month the price increased by 5.93%. In the past year, price decreased by -86.79%.
AVTE Latest News, Press Relases and Analysis
AVTE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 22.94 | 382.94B | ||
| AMGN | AMGEN INC | 14.63 | 172.20B | ||
| GILD | GILEAD SCIENCES INC | 14.97 | 152.10B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 24.02 | 106.91B | ||
| REGN | REGENERON PHARMACEUTICALS | 14.31 | 68.28B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 852.08 | 56.96B | ||
| ARGX | ARGENX SE - ADR | 62.07 | 51.25B | ||
| INSM | INSMED INC | N/A | 39.50B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.19 | 35.30B | ||
| NTRA | NATERA INC | N/A | 27.44B | ||
| BNTX | BIONTECH SE-ADR | N/A | 24.86B | ||
| BIIB | BIOGEN INC | 9.17 | 22.49B |
Related stock screener links
About AVTE
Company Profile
Aerovate Therapeutics, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. The company is headquartered in Waltham, Massachusetts and currently employs 4 full-time employees. The company went IPO on 2021-06-30. The firm is in the process of exploring strategic alternatives, which may include, but are not limited to, an acquisition, merger, reverse merger, business combination, liquidation or other transaction.
Company Info
AEROVATE THERAPEUTICS INC
930 Winter Street, Suite M-500
Waltham MASSACHUSETTS US
CEO: Timothy P. Noyes
Employees: 51
Phone: 16174432400
AEROVATE THERAPEUTICS INC / AVTE FAQ
Can you describe the business of AEROVATE THERAPEUTICS INC?
Aerovate Therapeutics, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. The company is headquartered in Waltham, Massachusetts and currently employs 4 full-time employees. The company went IPO on 2021-06-30. The firm is in the process of exploring strategic alternatives, which may include, but are not limited to, an acquisition, merger, reverse merger, business combination, liquidation or other transaction.
What is the stock price of AEROVATE THERAPEUTICS INC today?
The current stock price of AVTE is 2.68 USD.
Does AEROVATE THERAPEUTICS INC pay dividends?
AVTE does not pay a dividend.
How is the ChartMill rating for AEROVATE THERAPEUTICS INC?
AVTE has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Which stock exchange lists AVTE stock?
AVTE stock is listed on the Nasdaq exchange.
Can you provide the number of employees for AEROVATE THERAPEUTICS INC?
AEROVATE THERAPEUTICS INC (AVTE) currently has 51 employees.
AVTE Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to AVTE. When comparing the yearly performance of all stocks, AVTE is a bad performer in the overall market: 91.08% of all stocks are doing better.
AVTE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to AVTE. No worries on liquidiy or solvency for AVTE as it has an excellent financial health rating, but there are worries on the profitability.
AVTE Financial Highlights
Over the last trailing twelve months AVTE reported a non-GAAP Earnings per Share(EPS) of -2.44. The EPS increased by 15.28% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -86.68% | ||
| ROE | -91.1% | ||
| Debt/Equity | 0 |